Novonesis AS

Transaction in Own Shares • Sep 30, 2011

September 30, 2011

On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.

Under the program Novozymes will buy back B shares for an amount of up to DKK 400 million in the period from February 11, 2011, to December 31, 2011.

The following transactions have been made under the program:

	Number of	Average purchase	Transaction value,
	shares	price	DKK
Accumulated, last announcement	482,169		392,641,039
September 23, 2011	350	773.84	270,844
September 26, 2011	0		0
September 27, 2011	0		0
September 28, 2011	0		0
September 29, 2011	0		0
Accumulated under the program	482,519		392,911,883

Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 4,466 B shares in the period from September 23 to September 29. The shares related to these transactions were not part of the Safe Harbour share buyback program.

With the transactions stated above, Novozymes owns a total of 2,045,244 treasury shares, corresponding to 3.1% of the share capital. The total amount of shares in the company is 65,000,000, including treasury shares.

Contact persons:

Press and media: Investor relations: René Tronborg (Europe) Tel. (direct): +45 4446 2274 Tel. (mobile): +45 3077 2274

Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501 Tobias Bjorklund Tel. (direct): +45 4446 8682 Tel. (mobile): +45 3077 8682

Martin Riise Nielsen Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Company announcement no. 60, 2011 Page 1 of 1 Novozymes A/S Investor Relations

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27